PAVmed Inc.
PAVM
Positions held
Your positionsPAVM isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $21.51M | Enterprise value | $19.92M | Trailing P/E | — | Forward P/E | -1.13 |
| PEG | — | Price / book | 0.54 | Beta | 0.70 | Dividend yield | 0.00% |
| Revenue growth | 4.5% | Earnings growth | — | Gross margin | -2.2% | Operating margin | -212.8% |
| Profit margin | 0.0% | ROE | -64.8% | ROA | -39.7% | Debt / equity | 0.88 |
| Current ratio | 1.19 | Free cash flow | -$11.93M | Analyst recommendation | none | Mean target | $36.50 |
| 52w high | $28.44 | 52w low | $2.60 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.1M | $0.0M | $0.0M | — |
| Op margin | -20336.4% | -35759.1% | -12784.6% | -93620.0% | -77250.0% | — |
| Net income | -$5.4M | -$0.1M | -$1.3M | -$5.4M | -$11.9M | — |
| Gross margin | -269.7% | -340.9% | -63.5% | -1000.0% | -583.3% | — |
| Gross profit | -$0.1M | -$0.1M | -$0.0M | -$0.1M | -$0.0M | — |
| Operating income | -$6.7M | -$7.9M | -$6.6M | -$4.7M | -$4.6M | — |
- Revenue +50% vs prior quarter ($0.0M vs $0.0M).
- Gross margin -269.7% (was -340.9% prior quarter).
- Operating margin expanded to -20336.4%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.1M | $3.0M | $2.5M | $0.4M | — |
| Op margin | -30126.8% | -1481.7% | -2805.7% | -24161.0% | — |
| Net income | $0.4M | $39.8M | -$64.2M | -$89.0M | — |
| Gross margin | -207.0% | -61.6% | -161.8% | -858.6% | — |
| Gross profit | -$0.1M | -$1.8M | -$4.0M | -$3.2M | — |
| Operating income | -$21.4M | -$44.4M | -$68.8M | -$91.1M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-22 · Lucid Diagnostics Advances Multiple EsoGuard® and EsoCheck® Payment, Billing and Coding Pathways
2026-08-15 · PAVmed (PAVM) Q2 2026 Earnings Call Transcript
2026-08-14 · PAVmed Inc (PAVM) (Q2 2026) Earnings Call Highlights: Narrowing Losses and Strategic Progress ...
2026-08-14 · PAVmed Inc. Q2 2026 Earnings Call Summary
2026-08-14 · PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results
2026-08-13 · Lucid Diagnostics Provides Business Update and Reports Second Quarter 2026 Financial Results
2026-08-04 · Lucid Diagnostics to Participate in Upcoming Investor Conferences
2026-07-31 · PAVmed to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 14, 2026
2026-07-30 · Lucid Diagnostics to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 13, 2026
Price (daily)
Full chart · RSI · MACD · patterns